Jackson Creek Investment Advisors LLC Arcutis Biotherapeutics, Inc. Transaction History
Jackson Creek Investment Advisors LLC
- $371 Million
- Q2 2025
A detailed history of Jackson Creek Investment Advisors LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Jackson Creek Investment Advisors LLC holds 135,871 shares of ARQT stock, worth $2 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
135,871
Previous 113,536
19.67%
Holding current value
$2 Million
Previous $1.78 Million
7.26%
% of portfolio
0.51%
Previous 0.56%
Shares
3 transactions
Others Institutions Holding ARQT
# of Institutions
249Shares Held
124MCall Options Held
642KPut Options Held
197K-
Suvretta Capital Management, LLC New York, NY11.4MShares$168 Million7.82% of portfolio
-
Jennison Associates LLC11.1MShares$164 Million0.09% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$162 Million4.91% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$129 Million8.65% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$127 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $887M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...